Literature DB >> 7902015

C5a-induced myocardial ischemia: role for CD18-dependent PMN localization and PMN-platelet interactions.

M P Fletcher1, G L Stahl, J C Longhurst.   

Abstract

Intracoronary C5a in swine decreases coronary blood flow and regional myocardial segment shortening, responses mediated by thromboxane (Tx) A2-induced coronary vasoconstriction and intramyocardial trapping of granulocytes (PMNs). We sought to determine the origin of TxA2 and to investigate the role of CD18-dependent PMN function by utilizing an anti-CD18 monoclonal antibody, IB4. Isolated C5a-stimulated PMNs or platelets did not produce TxB2. However, together, C5a-stimulated PMNs and platelets produced TxB2. IB4 bound porcine PMN surface CD18 and blocked C5a-induced PMN functions. In vivo, IB4 loading (2 mg/kg) transiently decreased arterial blood pressure and circulating platelet counts in six of nine animals (390 +/- 31 vs. 176 +/- 41 X 10(6)/ml, control vs. IB4; P < 0.002) and significantly ameliorated C5a-induced decreases in coronary venous PMN count (-4.1 +/- 0.6 vs. -1.4 +/- 0.8 X 10(6) cells/ml), coronary artery blood flow (-10 +/- 1 vs. -4 +/- 1 ml/min), and segment shortening (-15 +/- 2 vs. -8 +/- 2%, C5a vs. C5a + IB4). We conclude that 1) production of TxB2 in response to C5a is mediated by a PMN-platelet interaction, 2) IB4 functionally blocks CD18 on porcine PMNs, and 3) C5a-induced myocardial PMN extraction is mediated, in part, by a CD18-dependent mechanism. These results suggest that PMN-platelet interactions and CD18-dependent PMN extraction are important in C5a-induced myocardial ischemia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7902015     DOI: 10.1152/ajpheart.1993.265.5.H1750

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  Complement activation promotes muscle inflammation during modified muscle use.

Authors:  J Frenette; B Cai; J G Tidball
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

Review 2.  Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future.

Authors:  Giuseppe De Luca; Stefano Savonitto; Arnoud W J van't Hof; Harry Suryapranata
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

3.  Absence of Gal epitope prolongs survival of swine lungs in an ex vivo model of hyperacute rejection.

Authors:  Bao-Ngoc H Nguyen; Agnes M Azimzadeh; Carsten Schroeder; Thomas Buddensick; Tianshu Zhang; Amal Laaris; Megan Cochrane; Henk-Jan Schuurman; David H Sachs; James S Allan; Richard N Pierson
Journal:  Xenotransplantation       Date:  2011 Mar-Apr       Impact factor: 3.907

4.  Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.

Authors:  C S Rinder; H M Rinder; B R Smith; J C Fitch; M J Smith; J B Tracey; L A Matis; S P Squinto; S A Rollins
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

5.  The role of C5a in the development of thrombotic glomerulonephritis in rats.

Authors:  C Kondo; M Mizuno; K Nishikawa; Y Yuzawa; N Hotta; S Matsuo
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

6.  Complement activation in patients with immune thrombocytopenic purpura according to phases of disease course.

Authors:  R Castelli; G Lambertenghi Delilliers; A Gidaro; M Cicardi; L Bergamaschini
Journal:  Clin Exp Immunol       Date:  2020-07-06       Impact factor: 4.330

7.  Xanthine oxidase, but not neutrophils, contributes to activation of cardiac sympathetic afferents during myocardial ischaemia in cats.

Authors:  Stephanie C Tjen-A-Looi; Liang-Wu Fu; John C Longhurst
Journal:  J Physiol       Date:  2002-08-15       Impact factor: 5.182

Review 8.  Complement activation and cardiac surgery: a novel target for improving outcomes.

Authors:  Gregory L Stahl; Stanton K Shernan; Peter K Smith; Jerrold H Levy
Journal:  Anesth Analg       Date:  2012-07-13       Impact factor: 5.108

9.  Complement-Mediated Enhancement of Monocyte Adhesion to Endothelial Cells by HLA Antibodies, and Blockade by a Specific Inhibitor of the Classical Complement Cascade, TNT003.

Authors:  Nicole M Valenzuela; Kimberly A Thomas; Arend Mulder; Graham C Parry; Sandip Panicker; Elaine F Reed
Journal:  Transplantation       Date:  2017-07       Impact factor: 4.939

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.